Abstract
The rates of cell proliferation and programmed cell death (apoptosis) reflect tumor cell dynamics and are considered to directly influence biological progression and tumor response to therapy. Bax and Bcl-2 are members of a gone family that influence apoptosis and have been used as surrogate markers in the evaluation of this process. Sixty-three fine-needle tumor samples from an equal number of patients with breast carcinomas were analyzed for Bax, Bcl-2, and DNA content by flow cytometry. The results were correlated with classical clinicopathological parameters. Bax values varied widely among tumors and showed no significant correlation with any of the clinicopathological parameters analyzed. Bcl-2 levels ranged from 4% to 91%, correlated positively with estrogen (P = 0.0004) and progesterone (P = 0.0045) receptor positivity, and were more associated with low S-phase tumor values. In contrast, high S-phase values correlated with estrogen receptor negativity, high grade, anti DNA aneuploidy. The study results indicate that Bcl-2 anti S-phase analysis of fine-needle samples of breast carcinomas provide a convenient tool for the assessment of these tumors. (C) 2000 Wiley-Liss, Inc.
Original language | English (US) |
---|---|
Pages (from-to) | 264-269 |
Number of pages | 6 |
Journal | Communications in Clinical Cytometry |
Volume | 42 |
Issue number | 5 |
DOIs | |
State | Published - Oct 15 2000 |
Externally published | Yes |
Keywords
- Bax
- Bcl-2
- Breast carcinoma
- Cytology
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Biophysics
- Hematology
- Endocrinology
- Cell Biology